Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy

被引:186
作者
Kemi, Ole Johan [1 ,2 ]
Ceci, Marcello [3 ,4 ]
Wisloff, Ulrik [2 ,5 ]
Grimaldi, Serena [3 ,4 ]
Gallo, Paolo [3 ,4 ]
Smith, Godfrey L. [1 ]
Condorelli, Gianluigi [3 ,4 ,6 ]
Ellingsen, Oyvind [2 ,5 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway
[3] Ist Ricovero & Cura Carattere Sci Multimed, Milan, Italy
[4] Fdn Parco Sci San Raffaele, Rome, Italy
[5] St Olavs Hosp, Dept Cardiol, Trondheim, Norway
[6] Univ Calif San Diego, Div Cardiol, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1002/jcp.21197
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiomyocyte hypertrophy differs according to the stress exerted on the myocardium. While pressure overload-induced cardiomyocyte hypertrophy is associated with depressed contractile function, physiological hypertrophy after exercise training associates with preserved or increased inotropy. We determined the activation state of myocardial Akt signaling with downstream substrates and fetal gene reactivation in exercise-induced physiological and pressure overload-induced pathological hypertrophies. C57BL/6J mice were either treadmill trained for 6 weeks, 5 days/week, at 85-90% of maximal oxygen uptake (VO2max), or underwent transverse aortic constriction (TAC) for 1 or 8 weeks. Total and phosphorylated protein levels were determined with SDS-PAGE, and fetal genes by real-time RT-PCR. In the physiologically hypertrophied heart after exercise training, total Akt protein level was unchanged, but Akt was chronically hyperphosphorylated at serine 473. This was accompanied by activation of the mammalian target of rapamycin (mTOR), measured as phosphorylation of its two substrates: the ribosomal protein S6 kinase-I (S6KI) and the eukaryotic translation initiation factor-4E binding protein-I (4E-BPI). Exercise training did not reactivate the fetal gene program (beta-myosin heavy chain, atrial natriuretic factor, skeletal muscle actin). In contrast, pressure overload after TAC reactivated fetal genes already after I week, and partially inactivated the Akt/mTOR pathway and downstream substrates after 8 weeks. In conclusion, changes in opposite directions of the myocardial Akt/mTOR signal pathway appears to distinguish between physiological and pathological hypertrophies; exercise training associating with activation and pressure overload associating with inactivation of the Akt/mTOR pathway.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
[41]   Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy [J].
Naskar, Shaon ;
Datta, Kaberi ;
Mitra, Arkadeep ;
Pathak, Kanchan ;
Datta, Ritwik ;
Bansal, Trisha ;
Sarkar, Sagartirtha .
PLOS ONE, 2014, 9 (08)
[42]   The role of Hippo signaling pathway in physiological cardiac hypertrophy [J].
Gholipour, Majid ;
Tabrizi, Arezoo .
BIOIMPACTS, 2020, 10 (04) :250-256
[43]   Physiological and pathological gestational cardiac hypertrophy: what can we learn from rodents? [J].
Sampaolesi, Maurilio ;
Van Calsteren, Kristel .
CARDIOVASCULAR RESEARCH, 2017, 113 (13) :1533-1535
[44]   NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt/mTOR and NFκB Signaling Pathways [J].
Zhao, Qingwei David ;
Viswanadhapalli, Suryavathi ;
Williams, Paul ;
Shi, Qian ;
Tan, Chunyan ;
Yi, Xiaolan ;
Bhandari, Basant ;
Abboud, Hanna E. .
CIRCULATION, 2015, 131 (07) :643-U152
[45]   Alterations in Signaling Pathways During Regression of Pathological Cardiac Hypertrophy [J].
Langager, Deanna ;
Leinwand, Leslie .
CIRCULATION RESEARCH, 2017, 121
[46]   A conserved role for phosphatidylinositol 3-kinase but not akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy [J].
O'Neill, Brian T. ;
Kim, Jaetaek ;
Wende, Adam R. ;
Theobald, Heather A. ;
Tuinei, Joseph ;
Buchanan, Jonathan ;
Guo, Aili ;
Zaha, Vlad G. ;
Davis, Don K. ;
Schell, John C. ;
Boudina, Sihem ;
Wayment, Benjamin ;
Litwin, Sheldon E. ;
Shioi, Tetsuo ;
Izumo, Seigo ;
Birnbaum, Morris J. ;
Abel, E. Dale .
CELL METABOLISM, 2007, 6 (04) :294-306
[47]   Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets [J].
Hou, Jianglong ;
Kang, Y. James .
PHARMACOLOGY & THERAPEUTICS, 2012, 135 (03) :337-354
[48]   Melatonin differentially regulates pathological and physiological cardiac hypertrophy: Crucial role of circadian nuclear receptor RORα signaling [J].
Xu, Longwei ;
Su, Yuanyuan ;
Zhao, Yichao ;
Sheng, Xincheng ;
Tong, Renyang ;
Ying, Xiaoying ;
Gao, Lingchen ;
Ji, Qingqi ;
Gao, Yu ;
Yan, Yang ;
Yuan, Ancai ;
Wu, Fujian ;
Lan, Feng ;
Pu, Jun .
JOURNAL OF PINEAL RESEARCH, 2019, 67 (02)
[49]   mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy [J].
Song, Xiaoxiao ;
Kusakari, Yoichiro ;
Xiao, Chun-Yang ;
Kinsella, Stuart D. ;
Rosenberg, Michael A. ;
Scherrer-Crosbie, Marielle ;
Hara, Kenta ;
Rosenzweig, Anthony ;
Matsui, Takashi .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 299 (06) :C1256-C1266
[50]   NO signaling in the CNS: from the physiological to the pathological [J].
Bishop, A ;
Anderson, JE .
TOXICOLOGY, 2005, 208 (02) :193-205